Koerdel, K.; Spitzner, M.; Meyer, T.; Engels, N.; Krause, F.; Gaedcke, J.; Conradi, L.-C.; Haubrock, M.; Beißbarth, T.; Leha, A.;
et al. NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy. Cancers 2021, 13, 455.
https://doi.org/10.3390/cancers13030455
AMA Style
Koerdel K, Spitzner M, Meyer T, Engels N, Krause F, Gaedcke J, Conradi L-C, Haubrock M, Beißbarth T, Leha A,
et al. NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy. Cancers. 2021; 13(3):455.
https://doi.org/10.3390/cancers13030455
Chicago/Turabian Style
Koerdel, Kristin, Melanie Spitzner, Thomas Meyer, Niklas Engels, Florian Krause, Jochen Gaedcke, Lena-Christin Conradi, Martin Haubrock, Tim Beißbarth, Andreas Leha,
and et al. 2021. "NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy" Cancers 13, no. 3: 455.
https://doi.org/10.3390/cancers13030455
APA Style
Koerdel, K., Spitzner, M., Meyer, T., Engels, N., Krause, F., Gaedcke, J., Conradi, L.-C., Haubrock, M., Beißbarth, T., Leha, A., Johnsen, S. A., Ghadimi, B. M., Rose-John, S., Grade, M., & Wienands, J.
(2021). NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy. Cancers, 13(3), 455.
https://doi.org/10.3390/cancers13030455